Jubilant Ingrevia has received approval for raising of funds up to Rs 600 crore by issuance of Commercial Paper (CP). The members of the Finance Committee, at its meeting held on August 18, 2023 has considered and approved the same.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.